In yesterday’s Wall Street session, Evolent Health Inc (NYSE:EVH) shares traded at $10.16, up 1.91% from the previous session.
EVH stock price is now -20.76% away from the 50-day moving average and -54.52% away from the 200-day moving average. The market capitalization of the company currently stands at $1.18B.
With the price target of $15, Needham recently initiated with Buy rating for Evolent Health Inc (NYSE: EVH). On December 03, 2024, BTIG Research reiterated its ‘Buy’ rating on the stock by increasing its target price from $36 to quote $29, while ‘Stephens’ rates the stock as ‘Equal-Weight’
In other news, McCarthy Daniel Joseph, PRESIDENT sold 23,693 shares of the company’s stock on Aug 22 ’24. The stock was sold for $731,790 at an average price of $30.89. Upon completion of the transaction, the PRESIDENT now directly owns 198,809 shares in the company, valued at $2.02 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 23 ’24, PRESIDENT McCarthy Daniel Joseph sold 10,469 shares of the business’s stock. A total of $339,008 was realized by selling the stock at an average price of $32.38. This leaves the insider owning 188,340 shares of the company worth $1.91 million. A total of 3.28% of the company’s stock is owned by insiders.
During the past 12 months, Evolent Health Inc has had a low of $9.93 and a high of $35.00. As of last week, the company has a debt-to-equity ratio of 0.79, a current ratio of 1.04, and a quick ratio of 1.04. The fifty day moving average price for EVH is $13.0872 and a two-hundred day moving average price translates $22.44615 for the stock.
The latest earnings results from Evolent Health Inc (NYSE: EVH) was released for 2024-09-30. The net profit margin was -4.23% and return on equity was -6.77% for EVH. The company reported revenue of $621.4 million for the quarter, compared to $511.01 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 21.6 percent.
